Evidence map›Paper›PMID 24856127›Full record

ArticleSurgery2014

Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Chun-Liang Chen, Jixin Yang, Iyore O A James, Hong-Yi Zhang, Gail E Besner

Abstract readEvaluation Study
In one paragraph

Article in Surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A tannin compound fromChinese medicine · 2019
    Article
  8. Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chun-Liang ChenDepartment of Pediatric Surgery, Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH; Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX.
Jixin YangDepartment of Pediatric Surgery, Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH.
Iyore O A JamesDepartment of Pediatric Surgery, Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH.
Hong-Yi ZhangDepartment of Pediatric Surgery, Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH.
Gail E BesnerDepartment of Pediatric Surgery, Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH. Electronic address: gail.besner@nationwidechildrens.org.
Nationwide Children's Hospital · US

Funding

HB-EGF and Intestinal Ischemia/ReperfusionR01GM061193 · NIGMS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BESNER, GAIL E · 2002 to 2014
$3.6M
HB-EGF Therapy for Necrotizing EntercolitisR01DK074611 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BESNER, GAIL E · 2007 to 2011
$1.4M
NIDDK NIH HHS R01 DK074611NIDDK NIH HHS R01 DK74611NIGMS NIH HHS R01 GM061193NIGMS NIH HHS R01 GM61193
6 · The paper itself

Abstract

backgroundWe have previously demonstrated that heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) protects the intestines from injury in several different experimental animal models. In the current study, we investigated whether the ability of HB-EGF to protect the intestines from ischemia/reperfusion (I/R) injury was related to its effects on Wnt/β-catenin signaling in intestinal stem cells (ISC).

methodsLucien-rich repeat-containing G-protein-coupled receptor 5 (LGR5)-enhanced green fluorescent protein (EGFP) transgenic (TG) mice with fluorescently labeled ISC, as well as the same mice treated with intraluminal HB-EGF or genetically engineered to overexpress HB-EGF, were exposed to segmental mesenteric artery occlusion (sMAO) to the terminal ilium. Wnt/β-catenin signaling was evaluated using immunofluorescent staining and Western blotting.

resultsLGR5 expression and Wnt/β-catenin signaling in the ISC of the terminal ilium of LGR5-EGFP TG mice was significantly reduced 24 hours after sMAO. Intraluminal administration of HB-EGF or HB-EGF overexpression in these mice led to preservation of LGR5 expression and Wnt/β-catenin signaling.

conclusionThese data show that HB-EGF preserves Wnt/β-catenin signaling in ISC after I/R injury.

Indexed as

AnimalsBlotting, WesternFluorescent Antibody TechniqueHeparin-binding EGF-like Growth FactorIleumIntercellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMice, TransgenicProtective AgentsRandom AllocationReceptors, G-Protein-CoupledReperfusion InjuryStem CellsWnt Signaling PathwayHbegf protein, mouseHeparin-binding EGF-like Growth FactorIntercellular Signaling Peptides and ProteinsLgr5 protein, mouseProtective AgentsReceptors, G-Protein-Coupled

Identifiers

PMID24856127
PMCPMC4034135
OpenAlexW1995789207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.